|
| Exchange Disseminated Time 08/05/2018 18:17:02 | Jyothy Laboratories Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on May 16, 2018, inter-alia to:
1. Consider and approve the Audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and year ended March 31, 2018;
2. Consider recommendation of dividend, if any, on the equity shares of the Company for the financial year 2017-18; and
3. Consider raising of funds by way of issuance of non-convertible debt securities in one or more tranches. |
|
|